Background Current therapies for autoimmune diseases still mainly suppress inflammation and only indirectly affect antigen-specific immune activities. Therapeutically targeting relevant autoantigens found in humans and animal models of RA has the potential to deliver maximal efficacy with minimal adverse effects.
Objectives This study was conducted with sera from patients with rheumatoid arthritis, systemic lupus erythematosus as well as with arthritis and lupus-like disease animal models to identify identical autoantigens in human and animal models for disease modifying use.
Methods Using protein filter technology (28000 human protein filter) the autoantigen profile of RA and SLE patients, mouse collagen and zymosan induced arthritis, as well as collagen and pristan induced arthritis in rats and TLR7, TLR9 deficient double-deficient and MyoD88 and Tir8 deficient mice of the MRL-lpr/lpr background were obtained. Cationic liposomes transferring siRNAs were used for the validation of their potential as therapeutic target in collagen induced arthritis in mice (CIA).
Results By high throughput methods using proteins filters, over 200 clones were identified to bind patient, mouse and rat autoantigens. We could identify that up to 90% of all autoantigens including anti-histone, snRNPs, hnRNP, t-RNA synthetases, PM, Scl2, HSP proteins, and 17 different ribosomal autoantigens are MyoD88 dependent and influenced by Tir8. We found 18 identical proteins targeted in human and animal situations of arthritis. In contrast, autoantigens such as citrullinated proteins are generated independently of MyoD88 Toll7, 9 and Tir8. Systemic administration of siRNAs in CIA mice inhibiting expression of Toll dependent autoantigens were used for the validation of their potential as therapeutic target in RA. These novel data indicate that nucleic acid-binding proteins are targeted in animal models and patients with RA. Systemic blocking of common RNA or DNA binding proteins overexpressed in synovial target tissue appears to modify arthritis.
Conclusions These novel data indicate that nucleic acid-binding proteins are targeted in animal models and patients with RA. Systemic blocking of common RNA or DNA binding proteins overexpressed in synovial target tissue appears to modify arthritis.
Disclosure of Interest None Declared
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.